Clinical trials in Covilha

8 clinical trials in Covilha, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PortugalEnsaios-Clinicos.pt

Covilha at a glance

clinical trials

Not yet recruiting0
Paediatric trials0
Research sites0

Quick filters

8 trials in Covilha

Open in trial search

Conjunctivitis allergic+3

Recruiting

Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

Investigational

Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

Investigational

Portugal

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dermatophagoides pteronyssinus enriched allergoid, mannan-conjugated, polymerised
Sponsor:Inmunotek S.L.

Contact Research Centre

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Recruiting

Investigational

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Finerenone
Sponsor:Colorado Prevention Center

Contact Research Centre

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Andexanet Alfa
Sponsor:Janssen Cilag International

Contact Research Centre

Arteriovenous graft thrombosis

Not recruiting

Study on MK-2060 for Preventing Blood Clots in Dialysis Patients with End-Stage Kidney Disease

Investigational

Study on MK-2060 for Preventing Blood Clots in Dialysis Patients with End-Stage Kidney Disease

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:MK-2060
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Bayer AG

Contact Research Centre

Hyperparathyroidism secondary

Not recruiting

Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

Investigational

Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Upacicalcet Sodium Hydrate
Sponsor:Pathalys Pharma Inc.

Contact Research Centre

Cardiovascular disorder

Not recruiting

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Janssen Cilag International

Contact Research Centre

Acute coronary syndrome

Not recruiting

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Janssen Cilag International

Contact Research Centre

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Covilha

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking trials focusing on atrial fibrillation and stroke prevention, evaluating novel therapeutic approaches to reduce cardiovascular events.

Stroke prevention in atrial fibrillation patients
Post-heart attack treatment optimization
Cardioembolic event prevention

Studies comparing innovative treatments to established medications for better patient outcomes.

02 Renal Disease Studies

Critical research addressing end-stage kidney disease complications, with particular focus on patients undergoing hemodialysis.

Secondary hyperparathyroidism treatment
Arteriovenous graft thrombosis prevention
Dialysis optimization

Evaluating new therapeutic options to improve quality of life for dialysis patients.

03 Neurological Interventions

Advanced research into acute ischemic stroke treatment and prevention of recurring cerebrovascular events.

Ischemic stroke management
High-risk TIA treatment
Systemic embolism prevention

Testing innovative therapies to reduce stroke risk and improve patient outcomes.

Back to Portugal All countries